Thyroid Cancer Awareness Month: What You Need to Know
For Thyroid Cancer Awareness Month, here’s a round-up of the latest news and updates in this disease space.
For Thyroid Cancer Awareness Month, here’s a round-up of the latest news and updates in this disease space:
- After it produced a 75% overall response rate across a range of tumor types, including thyroid cancer, Vitrakvi was approved by the Food and Drug Administration for the treatment of patients with NTRK fusions.
- Instead of undergoing surgery for potential cancer, many people with thyroid nodules can safely opt for surveillance.
- One patient shared her story about why she thinks her thyroid cancer diagnosis happened for a reason.
- For Nicole McGuinness, timing was everything when a friend told her a surgeon from nearly 500 miles away was looking for her after spotting a lump on her neck that turned out to be thyroid cancer — when he saw her on the HGTV show “Beachfront Bargain Hunt.”
- The first anaplastic thyroid cancer drug in 50 years was approved earlier this year — learn more about it in this roundup of the biggest rare cancer updates from the American Society of Clinical Oncology.
When the Daughter of a Pediatric Oncologist Receives a Cancer Diagnosis
October 14th 2021“We tried very hard, my daughter and I, to have a daughter-father relationship, not a daughter-doctor relationship,” said Dr. Michael Weiner on this episode of the “CURE® Talks Cancer” podcast, in which he discussed his career, his own cancer journey and his daughter’s diagnosis.
Listen
‘Monumental’ Treatment Advancements Have Been ‘Life-Changing’ For Many Patients With Thyroid Cancer
April 5th 2022Monumental treatment advancements over the past two decades have given patients with thyroid cancer the ability to live longer and better lives, according to an expert from Cleveland Clinic’s Taussig Cancer Institute. However, more work is needed to find curative treatments.
Read More
More Effective, Less Toxic Treatment Approach for Brain Metastases May Improve Care and Survival
March 2nd 2022Guidelines for the treatment of patients with brain metastases is moving from whole brain radiation therapy to less toxic treatment options to potentially improve care and increase survival.
Read More
Tafinlar Plus Mekinist May Safely Improve Long-Term Survival in Patients with Rare Thyroid Cancer
February 4th 2022After four years of additional follow-up, survival continued to improve and side effects remained tolerable in patients with anaplastic thyroid cancer receiving Tafinlar plus Mekinist.
Read More
